Elekta AB (publ) (OTCMKTS:EKTAY) Short Interest Update

Elekta AB (publ) (OTCMKTS:EKTAY) was the recipient of a significant drop in short interest in April. As of April 30th, there was short interest totalling 100 shares, a drop of 98.9% from the April 15th total of 9,400 shares. Based on an average daily volume of 38,600 shares, the short-interest ratio is presently 0.0 days.

Elekta AB (publ) Price Performance

Shares of EKTAY stock traded up $0.21 during trading hours on Friday, hitting $7.37. The stock had a trading volume of 7,412 shares, compared to its average volume of 16,554. The stock’s 50-day moving average price is $7.32 and its two-hundred day moving average price is $7.52. Elekta AB has a one year low of $6.52 and a one year high of $8.62. The stock has a market capitalization of $2.82 billion, a price-to-earnings ratio of 20.46 and a beta of 1.16.

Elekta AB (publ) (OTCMKTS:EKTAY) last issued its quarterly earnings data on Thursday, February 29th. The company reported $0.08 earnings per share (EPS) for the quarter. Elekta AB (publ) had a return on equity of 15.16% and a net margin of 7.88%. The business had revenue of $426.51 million for the quarter. As a group, equities research analysts predict that Elekta AB will post 0.41 earnings per share for the current fiscal year.

About Elekta AB (publ)

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.